Showing results (1-10 of 668) with videos related to
Sort By:
Pageof 67
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Anti-inflammatory and immune modulation therapy against atherosclerosis]Tomoya Yamashita, Ken-Ichi HirataClinical Calcium|December 4, 2004
[Calcium channel blockers and atherosclerosis]Ken-ichi Hirata, Mitsuhiro YokoyamaJournal of Echocardiography|January 16, 2016
Is speckle tracking actually helpful for cardiac resynchronization therapy?Hidekazu Tanaka, Ken-Ichi HirataHeart Failure Reviews|January 14, 2018
Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitusHidekazu Tanaka, Ken-Ichi HirataDiseases (Basel, Switzerland)|July 4, 2018
Gut Microbiome and Cardiovascular DiseasesNaofumi Yoshida, Tomoya Yamashita, Ken-Ichi HirataActa Medica Indonesiana|April 29, 2017
Regulatory T Cell Immunity in AtherosclerosisHilman Zulkifli Amin, Naoto Sasaki, Ken-Ichi HirataJournal of Atherosclerosis and Thrombosis|April 14, 2012
Regulatory T cells in atherogenesisNaoto Sasaki, Tomoya Yamashita, Masafumi Takeda, et al.European Heart Journal. Case Reports|March 16, 2022
Marked recovery of cardiac function by chemotherapy and autologous stem cell transplantation of a patient with heart failure with preserved ejection fraction due to primary amyloid light-chain amyloidosis: a case reportHidekazu Tanaka, Akihito Kitao, Hironobu Minami, et al.European Heart Journal. Case Reports|February 8, 2021
Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case reportKeiko Sumimoto, Yu Taniguchi, Noriaki Emoto, et al.Journal of Cardiology|March 7, 2015
Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular diseaseTomoya Yamashita, Naoto Sasaki, Kazuyuki Kasahara, et al.Pageof 67